Overview of the Republic of Korea Pharmacovigilance System
No hay miniatura disponible
Fecha
Título de la revista
ISSN de la revista
Título del volumen
Editor
World Bank, Washington, DC
Resumen
Descripción
Building capacity in countries to
conduct thorough surveillance of the use of all newly
authorized drugs and vaccines, both brand name and generic,
is a critical “public good” investment to ensure that drugs
work correctly and that their health benefits outweigh their
known risks. Korea’s pharmacovigilance system (PVS) is an
international best practice. It is the result of a
continuous and sustained government effort over the past
three decades—from small pilot projects to a nationwide
monitoring network—and offers valuable lessons to other
countries on the vital role that such a system can play in
ensuring the safety of drugs post-marketing. This report
provides an overview of the Korean pharmacovigilance system,
describing its main structural and operational elements, to
monitor the safety and effectiveness of medicines. It draws
from a review of available literature in journal articles,
as well as from the websites and reports of Korean institutions.
Palabras clave
DRUG SAFETY, DRUG REGULATION, PHARMACEUTICAL SAFETY SYSTEM, PEOPLE-CENTERED DRUG SAFETY POLICY, KOREA-WORLD BANK PARTNERSHIP TRUST FUND (KWPF), PHARMACOVIGILANC